{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044556","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.050685+00:00","generated_at":"2026-06-07T13:57:29.060412+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Elite Pharmaceuticals ships first order of generic Adderall XR to distributor Prasco","bullets":["First shipment of generic Adderall XR (5-30 mg extended-release amphetamine capsules) to Prasco, LLC.","Shipment under non-exclusive Mfg, Supply & Distribution Agreement dated April 5, 2023; Prasco markets under Burel label.","Product co-owned with Mikah Pharma; financial terms not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044556","json":"https://secwatch.observer/filing/0001493152-23-044556.json","markdown":"https://secwatch.observer/filing/0001493152-23-044556.md","text":"https://secwatch.observer/filing/0001493152-23-044556.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315223044556/0001493152-23-044556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315223044556/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:57:29.060412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}